Read More Pharma Industry News Panacea Biotec (NSE: PANACEABIO) names Rajinder Singh Manku to board while consolidated revenue rises in FY26 Find out how Panacea Biotec’s board change, FY26 loss and no-dividend call could shape investor sentiment after its latest results. byVenkateshMay 30, 2026